MED logo

MED
Medifast Inc

1,759
Mkt Cap
$139.99M
Volume
112,186.00
52W High
$15.46
52W Low
$9.22
PE Ratio
-6.91
MED Fundamentals
Price
$12.59
Prev Close
$12.69
Open
$12.67
50D MA
$10.61
Beta
0.62
Avg. Volume
191,562.02
EPS (Annual)
-$1.70
P/B
0.71
Rev/Employee
$1.02M
$39.30
Loading...
Loading...
News
all
press releases
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
MED beats first-quarter estimates despite steep revenue declines, while stronger coach productivity and a new product launch support recovery hopes.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
Zacks·4d ago
News Placeholder
Medifast Q1 Earnings Call Highlights
Medifast (NYSE:MED) reported first-quarter 2026 results that management characterized as an early step toward stabilizing the business as it pivots from traditional weight loss to a broader metabolic...
MarketBeat·5d ago
News Placeholder
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast (MED) delivered earnings and revenue surprises of +65.46% and +3.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
Medifast (NYSE:MED) Releases FY 2026 Earnings Guidance
Medifast (NYSE:MED) updated its FY 2026 earnings guidance. The company provided EPS guidance of -2.750--1.550 for the period, compared to the consensus estimate of -1.980. The company also issued...
MarketBeat·5d ago
News Placeholder
Medifast (NYSE:MED) Issues Q2 2026 Earnings Guidance
Medifast (NYSE:MED) updated its second quarter 2026 earnings guidance. The company provided EPS guidance of -1.000--0.500 for the period, compared to the consensus estimate of -0.430. The company...
MarketBeat·5d ago
News Placeholder
Medifast Announces First Quarter 2026 Financial Results
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter ended March 31, 2026. First...
Business Wire·5d ago
News Placeholder
Medifast's Q1 Earnings on The Horizon: Key Insights for Investors
MED reports Q1 fiscal 2026 May 4; revenue seen down 36.3% and EPS at a 55-cent loss as coach base and demand stay pressured.
Zacks·8d ago
News Placeholder
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended March 31, 2026 on...
Business Wire·19d ago
News Placeholder
Medifast (MED) to Release Earnings on Monday
Medifast (NYSE:MED) will be releasing its Q1 2026 earnings after the market closes on Monday, April 27. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-27-medifast-inc-stock...
MarketBeat·20d ago
<
1
2
...
>

Latest MED News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.